- Home
- MVBF vs OABI Comparison
MVBF vs OABI Comparison
Compare MVBF & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVBF
- OABI
- Stock Information
- Founded
- MVBF 1997
- OABI 2012
- Country
- MVBF United States
- OABI United States
- Employees
- MVBF N/A
- OABI N/A
- Industry
- MVBF Major Banks
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- MVBF Finance
- OABI Health Care
- Exchange
- MVBF Nasdaq
- OABI Nasdaq
- Market Cap
- MVBF 282.7M
- OABI 240.5M
- IPO Year
- MVBF N/A
- OABI N/A
- Fundamental
- Price
- MVBF $22.97
- OABI $2.01
- Analyst Decision
- MVBF Buy
- OABI Strong Buy
- Analyst Count
- MVBF 4
- OABI 3
- Target Price
- MVBF $24.50
- OABI $6.67
- AVG Volume (30 Days)
- MVBF 60.6K
- OABI 480.3K
- Earning Date
- MVBF 07-28-2025
- OABI 08-06-2025
- Dividend Yield
- MVBF 2.96%
- OABI N/A
- EPS Growth
- MVBF N/A
- OABI N/A
- EPS
- MVBF 1.29
- OABI N/A
- Revenue
- MVBF $143,378,000.00
- OABI $23,027,000.00
- Revenue This Year
- MVBF N/A
- OABI N/A
- Revenue Next Year
- MVBF $14.75
- OABI $45.02
- P/E Ratio
- MVBF $17.81
- OABI N/A
- Revenue Growth
- MVBF N/A
- OABI 6.05
- 52 Week Low
- MVBF $15.59
- OABI $1.22
- 52 Week High
- MVBF $25.13
- OABI $4.87
- Technical
- Relative Strength Index (RSI)
- MVBF 48.53
- OABI 54.14
- Support Level
- MVBF $23.12
- OABI $1.69
- Resistance Level
- MVBF $23.96
- OABI $2.09
- Average True Range (ATR)
- MVBF 0.59
- OABI 0.11
- MACD
- MVBF -0.08
- OABI -0.01
- Stochastic Oscillator
- MVBF 42.21
- OABI 80.25
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.